Effects of Melatonin on Sleep Architecture of Critically Ill Patients in the ICU

ConditionsCritical Illness ICU ICU Hospitalization Melatonin Sleep

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18+

SponsorRutgers, The State University of New Jersey

About this trial

This is a pilot study to examine the effects of melatonin on the sleep patterns of critically ill patients. Patients will have their sleep patterns measured with a device attached to their head with a headband then be given a dose of melatonin. Their participation in the study will last two days.

Eligibility criteria

Qualifiers

18 years or older, admitted to the ICU

Expected length of stay of at least 48 hours

Not mechanically ventilated

Able to take oral medications.

Disqualifiers

Mechanically ventilated

Currently using melatonin prior to ICU admission,

Have neurological conditions that may significantly alter sleep architecture, such as traumatic brain injury, stroke, or severe dementia.

Pregnant or lactating individuals

Trial design

Treatments tested in this trial

Melatonin

Treatment groups

30 Participants

are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Rutgers, The State University of New Jersey

Lead sponsor

Source ClinicalTrials.gov